Iovance Biotherapeutics Inc.
Organization details
- Legal name
- Iovance Biotherapeutics Inc.
- Former names
- Lion Biotechnologies, Inc. Genesis Biopharma, Inc Freight Management Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Carlos
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IOVA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001425205
- EIN
- 75-3254381
- Wikidata ID
- Q85769888
Board of directors
-
Athena Countouriotis · DirectorSince 2023
-
Frederick G. Vogt · Director · Interim CEO & General CounselSince 2024
-
Iain D. Dukes · DirectorSince 2023
-
Merrill A. Mcpeak · DirectorSince 2023
-
Michael Weiser · DirectorSince 2023
-
Ryan D. Maynard · DirectorSince 2023
-
Wayne P. Rothbaum · DirectorSince 2023
-
Wendy L. Yarno · DirectorSince 2023
Chief executives
Board connections
4 of this board's directors also sit on 8 other boards. 7 are in the same sector.
-
BioMarin Pharmaceutical Inc. Same sectorvia Athena Countouriotis
-
IDEAYA Biosciences Inc. Same sectorvia Wendy L. Yarno
-
ImageneBio Inc. Same sectorvia Iain D. Dukes
-
Inovio Pharmaceuticals Inc. Same sectorvia Wendy L. Yarno
-
Passage Bio Inc. Same sectorvia Athena Countouriotis
- via Merrill A. Mcpeak
-
Tarsus Pharmaceuticals Inc. Same sectorvia Wendy L. Yarno
-
Traws Pharma Inc. Same sectorvia Iain D. Dukes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Kirby Daniel Gordon Officer (Chief Commercial Officer) | Option exercise | +10,000 | — | — |
| Nov 10, 2026 | Kirby Daniel Gordon Officer (Chief Commercial Officer) | Shares withheld for tax | −3,935 | $8.08 | $31,795 |
| Nov 6, 2026 | Roche Corleen M. Officer (Chief Financial Officer) | Option exercise | +12,500 | — | — |
| Nov 6, 2026 | Roche Corleen M. Officer (Chief Financial Officer) | Shares withheld for tax | −5,311 | $8.04 | $42,700 |
| Sep 8, 2026 | BILINSKY IGOR Officer (Chief Operating Officer) | Option exercise | +7,813 | — | — |
| Sep 8, 2026 | Puri Raj K. Officer (Chief Regulatory Officer) | Option exercise | +9,766 | — | — |
| Sep 8, 2026 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Option exercise | +15,626 | — | — |
| Sep 8, 2026 | BILINSKY IGOR Officer (Chief Operating Officer) | Shares withheld for tax | −3,976 | $8.70 | $34,591 |
| Sep 8, 2026 | Puri Raj K. Officer (Chief Regulatory Officer) | Shares withheld for tax | −4,478 | $8.70 | $38,959 |
| Sep 8, 2026 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Shares withheld for tax | −6,638 | $8.70 | $57,751 |
| Sep 1, 2026 | BILINSKY IGOR Officer (Chief Operating Officer) | Option exercise | +8,789 | — | — |
| Sep 1, 2026 | Puri Raj K. Officer (Chief Regulatory Officer) | Option exercise | +5,470 | — | — |
| Sep 1, 2026 | Frederick G. Vogt Director, Officer (Interim CEO & General Counsel) | Option exercise | +41,669 | — | — |
| Sep 1, 2026 | BILINSKY IGOR Officer (Chief Operating Officer) | Shares withheld for tax | −4,472 | $8.28 | $37,028 |
| Sep 1, 2026 | Puri Raj K. Officer (Chief Regulatory Officer) | Shares withheld for tax | −2,508 | $8.28 | $20,766 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Iovance Biotherapeutics Inc.
Who is the CEO of Iovance Biotherapeutics Inc.?
Frederick G. Vogt is Iovance Biotherapeutics Inc.'s Interim CEO & General Counsel.
How many directors are on Iovance Biotherapeutics Inc.'s board?
Iovance Biotherapeutics Inc.'s board has 8 directors: Athena Countouriotis, Frederick G. Vogt, Iain D. Dukes, Merrill A. Mcpeak, Michael Weiser, Ryan D. Maynard, Wayne P. Rothbaum and Wendy L. Yarno.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="iovance-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.